|
[1]WANG JB,KANG HY,CAO XG,et al.The effect of LAM or ADV add-on therapy for HBeA g negative chronic hepatitis B patients with suboptimal response to PEG-IFN[J].Int J Virol,2015,22(5):310-314.(in Chinese)王建彬,康海燕,曹雪改,等.聚乙二醇干扰素应答不佳HBeA g阴性慢性乙肝患者加用拉米夫定或阿德福韦酯疗效观察[J].国际病毒学杂志,2015,22(5):310-314.
|
|
[2]IZZEDINE H,HULOT JS,LAUNAY-VACHER V,et al.Renal safety of adefovir dipivoxil in patients with chronic hepatitis B:two double-blind,randomized,placebo-controlled studies[J].Kidney Int,2004,66(3):1153-1158.
|
|
[3]MAO YM,ZENG MD.Adefovir dipivoxil——a new drug for hepatitis B[J].Chin J Hepatol,2004,12(1):61-63.(in Chinese)茅益民,曾民德.抗乙型病毒性肝炎新药——阿德福韦酯[J].中华肝胆病杂志,2004,12(1):61-63.
|
|
[4]GARA N,ZHAO X,COLLINS MT,et al.Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B[J].Aliment Pharmacol Ther,2012,35(11):1317-1325.
|
|
[5]WANG BF,WANG Y,WANG BY,et al.Osteomalacia and Fanconi's syndrome caused by long-term low-dose adefovir dipivoxil[J].J Clin Pharm Ther,2015,40(3):345-348.
|
|
[6]SHIMIZU M,FURUSYO N,IKEZAKI H,et al.Predictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis B[J].World J Gastroenterol,2015,21(7):2116-2123.
|
|
[7]WANG XB,ZHU XC,HUANG XY,et al.Fanconi syndrome due to prolonged use of low-dose adefovir[J].J Res Med Sci,2015,20(4):416-419.
|
|
[8]JEONG HJ,LEE JM,LEE TH,et al.Two cases of hypophosphatemic osteomalacia after long-term low dose adefovir therapy in chronic hepatitis b and literature review[J].J Bone Metab,2014,21(1):76-83.
|
|
[9]TANAKA M,SETOGUCHI T,ISHIDOU Y,et al.Pathological femoral fractures due to osteomalacia associated with adefovir dipivoxil treatment for hepatitis B:a case report[J].Diagn Pathol,2012,7:108.
|
|
[10]JIA HY,DING F,CHEN JY,et al.Early kidney injury during long-term adefovir dipivoxil therapy for chronic hepatitis B[J].World J Gastroenterol,2015,21(12):3657-3662.
|
DownLoad: